News
-
8 September 2020
BillionToOne secures EUA for RNA extraction-free Covid-19 test
Precision diagnostics company BillionToOne has received emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its Covid-19 diagnostic test, which doesn’t require RNA extraction.
-
7 September 2020
Maxim Biomedical to launch three million Covid-19 tests this year
Maxim Biomedical has revealed the plans to manufacture and market three million Maxim SARS-CoV-2 Rapid Antigen Diagnostic Tests for the diagnosis of Covid-19 by the end of the year.
-
7 September 2020
Roche’s test for Covid-19 and influenza A/B receives FDA EUA
The cobas SARS-CoV-2 & Influenza A/B Test developed by Roche for use on the cobas 6800/8800 Systems has received emergency use authorisation (EUA) from the US Food and Drug Administration...
-
3 September 2020
UK commits £500m for quick-result Covid-19 test trials
UK Government has pledged a £500m funding package to support the clinical trials of quick-result Covid-19 tests and to scale up the testing capacity in the country.
-
21 August 2020
COVID-19: Poll finds business sentiment is improving
The COVID-19 pandemic has cast doubts on the future prospects of businesses as customers remain wary of spending amid uncertainty. Verdict has been running a poll to assess the business...
-
21 August 2020
Personal protective equipment (PPE) supplies to hospitals insufficient and not reaching the needy: COVID-19 poll
Personal protective equipment such as masks and gloves are playing a vital role in reducing the transmission of COVID-19 and protecting frontline staff, especially those in healthcare.
-
20 August 2020
Concerns over the spread of COVID-19 declining since June: Poll
Fear of COVID-19 community transmission has been causing anxiety among the public as well as governments.
-
20 August 2020
Early data shows Fitbit devices can detect Covid-19 signs
Early data from a clinical study being performed by Fitbit has shown that the company's devices were able to detect physiological signs of Covid-19.
-
20 August 2020
UAE’s G42 Healthcare and Israel’s NanoScent partner for Covid-19 test
Abu Dhabi-based G42 Healthcare has signed a memorandum of understanding (MoU) with Israel’s NanoScent to develop, validate, manufacture and distribute a scent-reading solution to detect Covid-19.
-
17 August 2020
Saliva-based Covid-19 test receives EUA from FDA
The US Food and Drug Administration (FDA) has granted an emergency use authorisation (EUA) to SalivaDirect Covid-19 diagnostic test developed by Yale School of Public Health.